Sun, Aug 23, 2026
Ifeanyi O. Oshim1 
, Simon O. Azi2 , Ugonna C. Aniokete2 , Simon I. Okekpa3 , Evelyn U. Urama4 , Henshaw U. Okoroiwu3 , Promise U. Mbah5 , Lazarus A. Okoye6
, Simon O. Azi2 , Ugonna C. Aniokete2 , Simon I. Okekpa3 , Evelyn U. Urama4 , Henshaw U. Okoroiwu3 , Promise U. Mbah5 , Lazarus A. Okoye6
1- Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria; International Institute for Oncology, David Umahi Federal University of Health Sciences, PMB 211, Uburu Ebonyi State, Nigeria , oshimio@dufuhs.edu.ng
2- Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria; International Institute of Infectious Disease, Biosafety and Biosecurity, David Umahi Federal University of Health Sciences, PMB 211, Uburu Ebonyi State, Nigeria
3- Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria; International Institute for Oncology, David Umahi Federal University of Health Sciences, PMB 211, Uburu Ebonyi State, Nigeria
4- Department of Medical Microbiology and Public Health, Faculty of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nnewi, Anambra State, Nigeria
5- Department of Medical Laboratory Science, Imo State University, Owerri, Imo State, Nigeria
6- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Caritas University, Amorji-Nike, Emene, Enugu State, Nigeria
2- Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria; International Institute of Infectious Disease, Biosafety and Biosecurity, David Umahi Federal University of Health Sciences, PMB 211, Uburu Ebonyi State, Nigeria
3- Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria; International Institute for Oncology, David Umahi Federal University of Health Sciences, PMB 211, Uburu Ebonyi State, Nigeria
4- Department of Medical Microbiology and Public Health, Faculty of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nnewi, Anambra State, Nigeria
5- Department of Medical Laboratory Science, Imo State University, Owerri, Imo State, Nigeria
6- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Caritas University, Amorji-Nike, Emene, Enugu State, Nigeria
Abstract: (4624 Views)
Background: Evaluating the prevalence of malaria and its risk factors during pregnancy across various transmission contexts is necessary.
Methods: This cross-sectional study was conducted in a health facility in April and May, 2024. A convenience sampling technique was used to enroll 120 pregnant women attending antenatal care at a health center in South-South, Nigeria. A questionnaire was used to gather clinical and sociodemographic data. Blood smears were prepared using a standard technique. Factors associated with malaria were evaluated using Pearson's chi-square test, and a p-value of less than 0.05 was considered statistically significant.
Results: Among symptomatic pregnant women, the prevalence of malaria was 83.3% (100/120). The following factors were significantly associated with the prevalence of malaria in pregnant women with malaria symptoms: not being on antimalarial treatment for 1-5 months (p<0.001), having a higher degree (p<0.018), being primigravidae (p<0.001), being in the first trimester (p= 0.081), and being between 26 and 30 years old (p= 0.001).
Conclusion: Malaria remains a major public health concern among pregnant women, even though the rate of intervention with antimalarial drugs has increased in this region. Pregnant women who are at risk for these conditions should therefore receive additional care.
Methods: This cross-sectional study was conducted in a health facility in April and May, 2024. A convenience sampling technique was used to enroll 120 pregnant women attending antenatal care at a health center in South-South, Nigeria. A questionnaire was used to gather clinical and sociodemographic data. Blood smears were prepared using a standard technique. Factors associated with malaria were evaluated using Pearson's chi-square test, and a p-value of less than 0.05 was considered statistically significant.
Results: Among symptomatic pregnant women, the prevalence of malaria was 83.3% (100/120). The following factors were significantly associated with the prevalence of malaria in pregnant women with malaria symptoms: not being on antimalarial treatment for 1-5 months (p<0.001), having a higher degree (p<0.018), being primigravidae (p<0.001), being in the first trimester (p= 0.081), and being between 26 and 30 years old (p= 0.001).
Conclusion: Malaria remains a major public health concern among pregnant women, even though the rate of intervention with antimalarial drugs has increased in this region. Pregnant women who are at risk for these conditions should therefore receive additional care.
Research Article: Research Article |
Subject:
Parasitology
Received: 2024/10/6 | Accepted: 2025/06/11
Received: 2024/10/6 | Accepted: 2025/06/11
References
1. Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, et al. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg (Lond). 2022:81:104366. [View at Publisher] [DOI] [Google Scholar]
2. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64(1-2 Suppl):28-35. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004;17(4):760-9, table of contents. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Badmos AO, Alaran AJ, Adebisi YA, Bouaddi O, Onibon Z, Dada A, et al. What sub-Saharan African countries can learn from malaria elimination in China. Trop Med Health. 2021;49(1):86. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. World Health Organization Regional Office for Africa Brazzaville. 2004. [View at Publisher] [Google Scholar]
6. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg. 2003;97(1):30-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Fried M, Domingo GJ, Gowda CD, Mutabingwa TK, Duffy PE. Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp Parasitol. 2006;113(1):36-42. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Agomo CO, Oyibo WA, Anorlu RI, Agomo PU. Prevalence of malaria in pregnant women in Lagos, South-West Nigeria. Korean J Parasitol. 2009;47(2):179-83. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Borgella S, Fievet N, Huynh B-T, Ibitokou S, Hounguevou G, Affedjou J, et al. Impact of Pregnancy-Associated Malaria on Infant Malaria Infection in Southern Benin. PLOS ONE. 2013;8(11): e80624 [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Fana SA, Bunza MDA, Anka SA, Imam AU, Nataala SU. Prevalence and risk factors associated with malaria infection among pregnant women in a semi-urban community of north-western Nigeria. Infect Dis Poverty. 2015:4:24. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Agomo CO, Oyibo WA. Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria. Infect Dis Poverty. 2013;2(1):19. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Takem EN, D'Alessandro U. Malaria in pregnancy. Mediterr J Hematol Infect Dis. 2013;5(1):e2013010. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. World Health Organization (WHO). Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 8 (2016-2018). World Health Organization. 2015. [View at Publisher]
14. Desai M, O ter Kuile F, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria inpregnancy. Lancet Infect Dis. 2007;7(2):93-104. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science.1996;272(5267):1502–4. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Okoroiwu GIA. Prevalence of malaria and associated risk factors in pregnant women in mbaitoli local governmentarea, South-east Nigeria. Afr J Biomed Res. 2023;26(2):167-72. [View at Publisher] [DOI] [Google Scholar]
17. Suliman MA, Tamomh AG, Younis OY, Magboul AM, Mohammed HY, Hassan IM, et al. Malaria infection andassociated risk factors in pregnant women attending antenatal clinics in AI Jabalian locality, White Nile state, Sudan. Ann Parasitol. 2021;67(3):499-504. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Kiemde F, Sorgho H, Zango SH, Some GF, Rouamba T, Traore O, et al. Immunomodulatory effect of gestational age onblood cortisol and prolactin levels during pregnancy inmalaria endemic area. Res Square.2023;1:1-18. [View at Publisher] [DOI] [Google Scholar]
19. Umar S, Erhabor O, Abdulrahaman Y, Zama I, Onuigwe FU, Buhari H. Alterations in some hematological parameters, ascorbic acid and pantothenic acid levels among pregnant women with plasmodium parasitaemia in Sokoto, Nigeria. Sokoto Journal Laboratory Science. 2022;7(3):71-84 [View at Publisher] [DOI] [Google Scholar]
20. Bolaji O, Adekunle O, Adeyemo A, Ojewuyi A, Ajayi A, Rufai, A, et al. Prevalence of Plasmodium falciparium among pregnant women attending antenatal clinics in Osogbo, Osun State Nigeria. WNJMS. 2023;6(1):23-28 [View at Publisher] [Google Scholar]
21. Mangusho C, Mwebesa E, Izudi J, Aleni M, Driclle R, Ayaiasi RM, et al. High prevalence of malaria in pregnancy among women attending antenatal care at a large referral hospital in Northwestern Uganda: a cross-sectional study. PLoS ONE. 2023;18(4):0283755 [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Yusuf F, Sadau Y, Natasha P, Lai I. Effects of Malaria Parasitemia on Hematological Parameters of Pregnant Women Attending Gombe Specialist Hospital. BJST. 2023;7(1):397. [View at Publisher] [DOI] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Contact us
Tel & Fax: (+98) 17-32450093
E-mail:
goums.ac.ir
yahoo.com